DE LAURENTIIS, MICHELINO
DE LAURENTIIS, MICHELINO
Dipartimento di Medicina clinica e Chirurgia
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
1998 G., Fontanini; DE LAURENTIIS, Michelino; S., Vignati; S., Chinè; M., Lucchi; V., Silvestri; A., Mussi; DE PLACIDO, Sabino; Tortora, Giampaolo; Bianco, ANGELO RAFFAELE; W., Gullick; C. A., Angeletti; G., Bevilacqua; Ciardiello, Fortunato
Manuale di Oncologia Clinica
1996 Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo
Mitoxantrone, etoposide and bleomycin (MEB) chemotherapy in non-Hodgkin's Lymphoma patients non-elegible for standard cyclophosphamide, doxorubicin vincristine and prednisone (CHOP) combination.
1995 P., Tagliaferri; Matano, Elide; A., Rea; M., Famiani; F., Ciardiello; G., Tortora; V., Montesarchio; A., Morabito; M., Caraglia; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Palmieri, Giovannella; A. R., Bianco
Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer.
2004 Giuseppe Di, Lorenzo; Carmine, Pizza; Riccardo, Autorino; DE LAURENTIIS, Michelino; Ombretta, Marano; Adele, D'Alessio; Cancello, Giuseppe; Vincenzo, Altieri; Tortora, Giampaolo; Sisto, Perdonà; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Treatment of triple negative brest cancer (TNBC): current options and future perspectives.
2010 DE LAURENTIIS, Michelino; Cianniello, Daniela; Caputo, Roberta; Stanzione, Brigida; Arpino, Grazia; Cinieri, S; Lorusso, V; DE PLACIDO, Sabino
Targeted Therapy of Breast Cancer
2009 DE LAURENTIIS, Michelino; Zielinski, C.
EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) CORRELATES WITH DISEASE RELAPSE AND PROGRESSION TO ANDROGEN-INDEPEDENCE IN HUMAN PROSTATE CANCER.
2002 DI LORENZO, G; Tortora, G; D'Armiento, FRANCESCO PAOLO; DE ROSA, G; Staibano, Stefania; Autorino, R; D'Armiento, Maria; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Catalano, G; Bianco, Ar; Ciardiello, F.
External beam radiotherapy in bone metastatic prostate cancer: impact on patients’ pain relief and quality of life.
2003 DI LORENZO, G; Autorino, R; Ciardiello, F; Raben, D; Bianco, C; Troiani, T; Pizza, C; DE LAURENTIIS, Michelino; Pensabene, M; D., ARMIENTO M; Bianco, Ar; DE PLACIDO, Sabino
SECOND-LINE CHEMOTHERAPY WITH A HYBRID-ALTERNATING REGIMEN OF BOLUS FLUOROURACIL MODULATED BY METHOTREXATE AND INFUSIONAL FLUOROURACIL MODULATED BY FOLINIC ACID IN PATIENTS WITH METASTATIC COLORECTAL CANCERPRETREATED WITH FLUOROURACIL. A PHASE II STUDY.
2002 Carlomagno, C; DE LAURENTIIS, Michelino; Lauria, R; Arpino, Grazia; Massarelli, E; Ferrara, C; Milano, A; VERNAGLIA LOMBARDI, A; Costanzo, R; Catalano, G; Bianco, Ar; DE PLACIDO, Sabino
Differential immunohistochemical detection of transforming growth factor , amphiregulin and CRIPTO in human normal and malignant breast tissues.
1996 Panico, L.; D'Antonio, A.; Salvatore, G.; Mazza, E.; Tortora, Giampaolo; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Giordano, T.; Merino, M.; Salomon, D. S.; Gullick, W. J.; Pettinato, Guido; Bianco, A. R.; Ciardiello, F.
Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A.
1996 Ciardiello, Fortunato; Damiano, Vincenzo; Bianco, Roberto; C., Bianco; G., Fontanini; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; J., Mendelsohn; Bianco, ANGELO RAFFAELE; Tortora, Giampaolo
A-Interferon potentiates the growth inhibitory effects of anti-transferrin receptor monoclonal antibodies.
1996 Caraglia, M.; Leardi, A.; Ricciardi, B.; DE LAURENTIIS, Michelino; Lentini, M. L.; Graziano, ; Matano, Elide; DE PLACIDO, Sabino; Bianco, ANGELO RAFFAELE; Tagliaferri, P.
[Exemestane in the treatment of breast carcinoma: recent findings]
2008 DE LAURENTIIS, Michelino; Carmen, Criscitiello; Agnese, Montanino; Claudette, Falato; Monica, Plaitano
Targeting HER2 as a therapeutic strategy for breast cancer: a paradigmatic shift of drug development in oncology.
2005 DE LAURENTIIS, Michelino; Cancello, G; Zinno, L; Montagna, E; Malorni, L; Esposito, A; Pennacchio, R; Silvestro, L; Giuliano, Mario; Giordano, A; Caputo, F; Accurso, A; DE PLACIDO, Sabino
NUCLEAR DNA CONTENT-DERIVED PARAMETERS CORRELATED WITH HETEROGENEOUS EXPRESSION PF P53 AND BCL-2 PROTEINS IN CLEAR CELL RENAL CARCINOMA
2000 Pepe, S; Ruggiero, A; D'Acquisto, M; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino
Survival Analysis by means of a novel Neural Network Model
2003 Eleuteri, A; Tagliaferri, R; DE PLACIDO, Sabino; DE LAURENTIIS, Michelino
A Feasibilty Study of a Sequential Dose-Dense Adjuvant Regimen with Epidoxorubicin Followed by Docetaxel Followed by High-Dose Cyclophosphamide for Early Breast Cancer with 4 or More Lymph Node Metastases.
2001 Francesco, Cognetti; Arpino, Grazia; DE LAURENTIIS, Michelino; Paola, Papaldo; Chiara, Sguotti; Modesto, D'Aprile; Francesco, Recchia; DE PLACIDO, Sabino; Angelo Raffaele, Bianco
A metanalysis of interaction between HER2 and the response to endocrine therapy (ET) in metastatic breast cancer (MBC)”,
2000 DE LAURENTIIS, Michelino; Arpino, Grazia; E., Massarelli; C., Carlomagno; F., Ciardiello; G., Tortora; Ar, Bianco; DE PLACIDO, Sabino
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
2010 Correa, C; Mcgale, P; Taylor, C; Wang, Y; Clarke, M; Davies, C; Peto, R; Bijker, N; Solin, L; Darby, S; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; Carlomagno, Chiara; DE PLACIDO, Sabino
Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELOX-TARAV) in first line colorectal cancer: run in part
2007 G., Tortora; Carlomagno, Chiara; Bianco, Roberto; Daniele, G; Pepe, S; Leopardo, D; Marciano, Roberta; DE LAURENTIIS, Michelino; F., Ciardiello; DE PLACIDO, Sabino
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. | 1.1 Articolo in rivista | 1998 | G., Fontanini; DE LAURENTIIS, Michelino; S., Vignati; S., Chinè; M., Lucchi; V., Silvestri; A., Mussi; DE PLACIDO, Sabino; Tortora, Giampaolo; Bianco, ANGELO RAFFAELE; W., Gullick; C. A., Angeletti; G., Bevilacqua; Ciardiello, Fortunato | |
| Manuale di Oncologia Clinica | 2.1 Contributo in volume (Capitolo o Saggio) | 1996 | Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo | |
| Mitoxantrone, etoposide and bleomycin (MEB) chemotherapy in non-Hodgkin's Lymphoma patients non-elegible for standard cyclophosphamide, doxorubicin vincristine and prednisone (CHOP) combination. | 1.1 Articolo in rivista | 1995 | P., Tagliaferri; Matano, Elide; A., Rea; M., Famiani; F., Ciardiello; G., Tortora; V., Montesarchio; A., Morabito; M., Caraglia; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Palmieri, Giovannella; A. R., Bianco | |
| Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer. | 1.1 Articolo in rivista | 2004 | Giuseppe Di, Lorenzo; Carmine, Pizza; Riccardo, Autorino; DE LAURENTIIS, Michelino; Ombretta, Marano; Adele, D'Alessio; Cancello, Giuseppe; Vincenzo, Altieri; Tortora, Giampaolo; Sisto, Perdonà; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| Treatment of triple negative brest cancer (TNBC): current options and future perspectives. | 1.1 Articolo in rivista | 2010 | DE LAURENTIIS, Michelino; Cianniello, Daniela; Caputo, Roberta; Stanzione, Brigida; Arpino, Grazia; Cinieri, S; Lorusso, V; DE PLACIDO, Sabino | |
| Targeted Therapy of Breast Cancer | 8.01 Chairman di Sessioni di Convegni Internazionali | 2009 | DE LAURENTIIS, Michelino; Zielinski, C. | |
| EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) CORRELATES WITH DISEASE RELAPSE AND PROGRESSION TO ANDROGEN-INDEPEDENCE IN HUMAN PROSTATE CANCER. | 1.1 Articolo in rivista | 2002 | DI LORENZO, G; Tortora, G; D'Armiento, FRANCESCO PAOLO; DE ROSA, G; Staibano, Stefania; Autorino, R; D'Armiento, Maria; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Catalano, G; Bianco, Ar; Ciardiello, F. | |
| External beam radiotherapy in bone metastatic prostate cancer: impact on patients’ pain relief and quality of life. | 2.1 Contributo in volume (Capitolo o Saggio) | 2003 | DI LORENZO, G; Autorino, R; Ciardiello, F; Raben, D; Bianco, C; Troiani, T; Pizza, C; DE LAURENTIIS, Michelino; Pensabene, M; D., ARMIENTO M; Bianco, Ar; DE PLACIDO, Sabino | |
| SECOND-LINE CHEMOTHERAPY WITH A HYBRID-ALTERNATING REGIMEN OF BOLUS FLUOROURACIL MODULATED BY METHOTREXATE AND INFUSIONAL FLUOROURACIL MODULATED BY FOLINIC ACID IN PATIENTS WITH METASTATIC COLORECTAL CANCERPRETREATED WITH FLUOROURACIL. A PHASE II STUDY. | 2.1 Contributo in volume (Capitolo o Saggio) | 2002 | Carlomagno, C; DE LAURENTIIS, Michelino; Lauria, R; Arpino, Grazia; Massarelli, E; Ferrara, C; Milano, A; VERNAGLIA LOMBARDI, A; Costanzo, R; Catalano, G; Bianco, Ar; DE PLACIDO, Sabino | |
| Differential immunohistochemical detection of transforming growth factor , amphiregulin and CRIPTO in human normal and malignant breast tissues. | 1.1 Articolo in rivista | 1996 | Panico, L.; D'Antonio, A.; Salvatore, G.; Mazza, E.; Tortora, Giampaolo; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Giordano, T.; Merino, M.; Salomon, D. S.; Gullick, W. J.; Pettinato, Guido; Bianco, A. R.; Ciardiello, F. | |
| Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. | 1.1 Articolo in rivista | 1996 | Ciardiello, Fortunato; Damiano, Vincenzo; Bianco, Roberto; C., Bianco; G., Fontanini; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; J., Mendelsohn; Bianco, ANGELO RAFFAELE; Tortora, Giampaolo | |
| A-Interferon potentiates the growth inhibitory effects of anti-transferrin receptor monoclonal antibodies. | 1.1 Articolo in rivista | 1996 | Caraglia, M.; Leardi, A.; Ricciardi, B.; DE LAURENTIIS, Michelino; Lentini, M. L.; Graziano, ; Matano, Elide; DE PLACIDO, Sabino; Bianco, ANGELO RAFFAELE; Tagliaferri, P. | |
| [Exemestane in the treatment of breast carcinoma: recent findings] | 1.1 Articolo in rivista | 2008 | DE LAURENTIIS, Michelino; Carmen, Criscitiello; Agnese, Montanino; Claudette, Falato; Monica, Plaitano | |
| Targeting HER2 as a therapeutic strategy for breast cancer: a paradigmatic shift of drug development in oncology. | 1.1 Articolo in rivista | 2005 | DE LAURENTIIS, Michelino; Cancello, G; Zinno, L; Montagna, E; Malorni, L; Esposito, A; Pennacchio, R; Silvestro, L; Giuliano, Mario; Giordano, A; Caputo, F; Accurso, A; DE PLACIDO, Sabino | |
| NUCLEAR DNA CONTENT-DERIVED PARAMETERS CORRELATED WITH HETEROGENEOUS EXPRESSION PF P53 AND BCL-2 PROTEINS IN CLEAR CELL RENAL CARCINOMA | 1.1 Articolo in rivista | 2000 | Pepe, S; Ruggiero, A; D'Acquisto, M; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino | |
| Survival Analysis by means of a novel Neural Network Model | 1.1 Articolo in rivista | 2003 | Eleuteri, A; Tagliaferri, R; DE PLACIDO, Sabino; DE LAURENTIIS, Michelino | |
| A Feasibilty Study of a Sequential Dose-Dense Adjuvant Regimen with Epidoxorubicin Followed by Docetaxel Followed by High-Dose Cyclophosphamide for Early Breast Cancer with 4 or More Lymph Node Metastases. | 4.1 Articoli in Atti di convegno | 2001 | Francesco, Cognetti; Arpino, Grazia; DE LAURENTIIS, Michelino; Paola, Papaldo; Chiara, Sguotti; Modesto, D'Aprile; Francesco, Recchia; DE PLACIDO, Sabino; Angelo Raffaele, Bianco | |
| A metanalysis of interaction between HER2 and the response to endocrine therapy (ET) in metastatic breast cancer (MBC)”, | 8.02 Comunicazioni a Convegni o Seminari | 2000 | DE LAURENTIIS, Michelino; Arpino, Grazia; E., Massarelli; C., Carlomagno; F., Ciardiello; G., Tortora; Ar, Bianco; DE PLACIDO, Sabino | |
| Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. | 1.1 Articolo in rivista | 2010 | Correa, C; Mcgale, P; Taylor, C; Wang, Y; Clarke, M; Davies, C; Peto, R; Bijker, N; Solin, L; Darby, S; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; Carlomagno, Chiara; DE PLACIDO, Sabino | |
| Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELOX-TARAV) in first line colorectal cancer: run in part | 1.5 Abstract in rivista | 2007 | G., Tortora; Carlomagno, Chiara; Bianco, Roberto; Daniele, G; Pepe, S; Leopardo, D; Marciano, Roberta; DE LAURENTIIS, Michelino; F., Ciardiello; DE PLACIDO, Sabino |